Clinical trial

A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents

NCT02714062

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-03-01

PhasePHASE4

Study timeline

Study start (actual)2016-03-01Date precision: month

Registry last updated2022-08-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pediatric Obesityunresolved

Childhood Obesityunresolved

Interventions

PlaceboDRUG

VI-0521 Mid DoseDRUG

VI-0521 Top DoseDRUG

Sponsors & collaborators

VIVUS LLClead sponsor

Mapped research locations

CincinnatiOhio, United States1 CharlestonSouth Carolina, United States1 Baton RougeLouisiana, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02714062 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.